Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Are Antibody Tests Alone Enough to Detect HIV?

By LabMedica International staff writers
Posted on 30 Jun 2009
Antibody tests alone were insufficient to detect human immunodeficiency virus (HIV) in individuals.

Diagnosis of acute HIV infection relies on detection of HIV virus using viral load tests, or p24 antigen. More...
Pooled HIV viral load testing has been shown to be an effective means of diagnosing acute infections. However, it is slow, typically taking between 7 and 21 days to obtain the results, cumbersome, and laborious. It is, therefore, not a realistic technology for resource-limited settings, or for addressing the problem of ongoing transmission from people during acute infection.

The use of a test that combines rapid testing for HIV antibodies with an ultrasensitive p24 assay is an alternative. This should detect HIV infection several weeks earlier than previous generations of antibody tests in people recently infected. These fourth generation assays are now routinely used in some countries such as the United Kingdom.

Professor Susan H. Eshelman from the department of pathology, Johns Hopkins Medical Institutions (Baltimore, MD, USA), and colleagues used the Abbott (Abbott park, IL, USA) Architect HIV antigen/antibody (Ag/Ab) combo assay, to detect individuals with acute HIV-1 infection.

Testing for the antigen reduces the window period in which an individual might have been exposed to HIV and has a reactive test result. Thus, individuals exposed to HIV could test reactive for the antigen, but might not test reactive to the antibody. In this study, the Abbott combination assay detected 61.9 % of the acute infections whereas only 14.3 % of the acute samples were identified as positive by a third-generation antibody test. There were 21 acute infections among 217 samples from seronegative individuals.

The study was published online in the Journal of Acquired Immune Deficiency Syndromes (JAIDS), June 2009.

Related Links:
Johns Hopkins Medical Institutions
Abbott



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.